Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

AKYA Akoya BioSciences Inc

4,00

0,01 (0,25%)

Zuletzt aktualisiert: 17:44:14

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Akoya BioSciences Charts.

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Akoya BioSciences Charts.

News Akoya BioSciences Inc

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
Donnerstag 2 Mai 2024 (1 Tag vor) • GlobeNewswire Inc.

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
Montag 22 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
Freitag 5 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
Montag 4 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Montag 12 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
Donnerstag 8 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Akoya BioSciences Inc News-Artikel

Deutsche Lufthansa

BNP Paribas (QX)

Deutsche Telekom (QX)

Health Care Select Sector

Euro vs Sterling

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen